<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39358705</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>03</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>05</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2334</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>02</Day></PubDate></JournalIssue><Title>BMC infectious diseases</Title><ISOAbbreviation>BMC Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Hesitation towards COVID-19 booster vaccination among dialysis patients: a cross-sectional study in Taizhou, China.</ArticleTitle><Pagination><StartPage>1095</StartPage><MedlinePgn>1095</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1095</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12879-024-09917-6</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">This research aimed to explore hesitation towards the COVID-19 booster vaccine among dialysis patients and study the association between COVID-19 pandemic-induced health behavior and vaccination hesitancy.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A self-administered online questionnaire evaluating dialysis patients' hesitation to take COVID-19 booster vaccination was conducted between March 24 and 22 April 2022 in Taizhou, China. The logistic regression method was applied to identify factors associated with vaccination hesitancy, and all data were analyzed using R software.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the 365 study participants, 272 (74.5%) individuals hesitated to take the booster dose. Health behavior was found to be a significant factor for hesitation to take COVID-19 vaccines, with OR (95% CI) of 1.09 (1.02-1.17). Influenza vaccination history was also significantly associated with the hesitation (OR (95% CI) = 0.39 (0.21-0.74)). In addition, participants with higher education levels exhibited lower vaccine hesitancy compared to those with junior secondary or below, with ORs (95% CIs) of 0.49 (0.27-0.91) for senior secondary and 0.35 (0.14-0.89) for junior college or above, respectively.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The proportion of hesitancy for taking the booster vaccination of the COVID-19 vaccine was high among dialysis patients. Health behaviors, influenza vaccination history, and education levels were risk factors in their vaccination hesitancy. These findings may aid efforts to help vaccinate people with underlying diseases against future pandemics.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Chengwen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Evidence-based Medicine Center, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai, Zhejiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tung</LastName><ForeName>Tao-Hsin</ForeName><Initials>TH</Initials><AffiliationInfo><Affiliation>Evidence-based Medicine Center, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai, Zhejiang, China. ch2876@yeah.net.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Taizhou Institute of Medicine, Health and New Drug Clinical Research, Taizhou, China. ch2876@yeah.net.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Jian-Sheng</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai, Zhejiang, China. zhujs@enzemed.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Infect Dis</MedlineTA><NlmUniqueID>100968551</NlmUniqueID><ISSNLinking>1471-2334</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007117" MajorTopicYN="Y">Immunization, Secondary</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006435" MajorTopicYN="Y">Renal Dialysis</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000088823" MajorTopicYN="Y">Vaccination Hesitancy</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015438" MajorTopicYN="N">Health Behavior</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">China</Keyword><Keyword MajorTopicYN="N">Dialysis patient</Keyword><Keyword MajorTopicYN="N">Health behavior</Keyword><Keyword MajorTopicYN="N">Hesitation</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>3</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>3</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>2</Day><Hour>23</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39358705</ArticleId><ArticleId IdType="pmc">PMC11445873</ArticleId><ArticleId IdType="doi">10.1186/s12879-024-09917-6</ArticleId><ArticleId IdType="pii">10.1186/s12879-024-09917-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alwan N. Surveillance is underestimating the burden of the COVID-19 pandemic. Lancet. 2020;396(10252):e24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7836224</ArticleId><ArticleId IdType="pubmed">32861312</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Q, Bao L, Mao H, Wang L, Xu K, Yang M, et al. Development of an inactivated vaccine candidate for SARS-CoV-2. Science. 2020;369(6499):77–81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7202686</ArticleId><ArticleId IdType="pubmed">32376603</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodd R, Cvejic E, Bonner C, Pickles K, McCaffery K. Group SHLLC-. Willingness to vaccinate against COVID-19 in Australia. Lancet Infect Dis. 2021;21(3):318–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7326391</ArticleId><ArticleId IdType="pubmed">32619436</ArticleId></ArticleIdList></Reference><Reference><Citation>Veronese N, Saccaro C, Demurtas J, Smith L, Dominguez L, Maggi S, et al. Prevalence of unwillingness and uncertainty to vaccinate against COVID-19 in older people: a systematic review and meta-analysis. Ageing Res Rev. 2021;72:101489.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8516660</ArticleId><ArticleId IdType="pubmed">34662744</ArticleId></ArticleIdList></Reference><Reference><Citation>Trogen B, Oshinsky D, Caplan A. Adverse consequences of rushing a SARS-CoV-2 vaccine: implications for public trust. JAMA. 2020;323(24):2460–1.</Citation><ArticleIdList><ArticleId IdType="pubmed">32453392</ArticleId></ArticleIdList></Reference><Reference><Citation>MacDonald N, Hesitancy SWGV. Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015;33(34):4161–4.</Citation><ArticleIdList><ArticleId IdType="pubmed">25896383</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z, Ji Y, Sun X. The impact of vaccine hesitation on the intentions to get COVID-19 vaccines: the use of the health belief model and the theory of planned behavior model. Front Public Health. 2022;10:882909.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9615565</ArticleId><ArticleId IdType="pubmed">36311575</ArticleId></ArticleIdList></Reference><Reference><Citation>Naaber P, Tserel L, Kangro K, Sepp E, Jürjenson V, Adamson A, et al. Dynamics of antibody response to BNT162b2 vaccine after six months: a longitudinal prospective study. Lancet Reg Health Eur. 2021;10:100208.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8418937</ArticleId><ArticleId IdType="pubmed">34514454</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo C, Zhang M, Jiang E, Jin M, Tung T, Zhu J. The main decision-making competence for willingness-to-pay towards COVID-19 vaccination: a family-based study in Taizhou, China. Ann Med. 2022;54(1):2376–84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9423852</ArticleId><ArticleId IdType="pubmed">36004802</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis D. Will Omicron finally overpower China’s COVID. Defences? Nat. 2022;604(7904):17–8.</Citation><ArticleIdList><ArticleId IdType="pubmed">35347306</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazarus J, Ratzan S, Palayew A, Gostin L, Larson H, Rabin K, et al. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2021;27(2):225–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7573523</ArticleId><ArticleId IdType="pubmed">33082575</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K, Wong E, Ho K, Cheung A, Yau P, Dong D, et al. Change of willingness to accept COVID-19 vaccine and reasons of vaccine hesitancy of working people at different waves of local epidemic in Hong Kong, China: repeated cross-sectional surveys. Vaccines (Basel). 2021;9(1):62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7832291</ArticleId><ArticleId IdType="pubmed">33477725</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Jing R, Lai X, Zhang H, Lyu Y, Knoll M, et al. Acceptance of COVID-19 vaccination during the COVID-19 pandemic in China. Vaccines (Basel). 2020;8(3):482.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7565574</ArticleId><ArticleId IdType="pubmed">32867224</ArticleId></ArticleIdList></Reference><Reference><Citation>O’Driscoll M, Ribeiro Dos Santos G, Wang L, Cummings D, Azman A, Paireau J, et al. Age-specific mortality and immunity patterns of SARS-CoV-2. Nature. 2021;590(7844):140–5.</Citation><ArticleIdList><ArticleId IdType="pubmed">33137809</ArticleId></ArticleIdList></Reference><Reference><Citation>Reyes-Sánchez F, Basto-Abreu A, Torres-Alvarez R, Canto-Osorio F, González-Morales R, Dyer-Leal D, et al. Fraction of COVID-19 hospitalizations and deaths attributable to chronic diseases. Prev Med. 2022;155:106917.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8674104</ArticleId><ArticleId IdType="pubmed">34921832</ArticleId></ArticleIdList></Reference><Reference><Citation>Sertbas Y, Solak E, Dagci S, Kizilay V, Yazici Z, Elarslan S, et al. Clinical outcomes of COVID-19 in patients with chronic diseases. North Clin Istanb. 2023;10(4):401–10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10500237</ArticleId><ArticleId IdType="pubmed">37719255</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanchi S, Torreggiani M, Chatrenet A, Fois A, Mazé B, Njandjo L, et al. COVID-19 vaccine hesitancy in patients on dialysis in Italy and France. Kidney Int Rep. 2021;6(11):2763–74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8425747</ArticleId><ArticleId IdType="pubmed">34518807</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdulaziz H, Saleh M, Elrggal M, Omar M, Hawash S, Attiya A, et al. Egyptian hemodialysis patients’ willingness to receive the COVID-19 vaccine booster dose: a multicenter survey. J Nephrol. 2023;36(5):1329–40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9979119</ArticleId><ArticleId IdType="pubmed">36862285</ArticleId></ArticleIdList></Reference><Reference><Citation>Fajar J, Sallam M, Soegiarto G, Sugiri Y, Anshory M, Wulandari L, et al. Global prevalence and potential influencing factors of COVID-19 vaccination hesitancy: a meta-analysis. Vaccines. 2022;10(8):1356.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9412456</ArticleId><ArticleId IdType="pubmed">36016242</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin X, Zhang M, Chen Y, Xue J, Chen H, Tung T, et al. Relationship between knowledge, attitudes, and practices and COVID-19 vaccine hesitancy: a cross-sectional study in Taizhou, China. Front Med (Lausanne). 2022;9:770933.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9445127</ArticleId><ArticleId IdType="pubmed">36082277</ArticleId></ArticleIdList></Reference><Reference><Citation>Thanapluetiwong S, Chansirikarnjana S, Charernwat P, Saranburut K, Ittasakul P. Prevalence and factors associated with caregivers’ hesitancy in immunizing dependent older adults with COVID-19 vaccines: a cross-sectional survey. Vaccines (Basel). 2022;10(10):1748.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9612071</ArticleId><ArticleId IdType="pubmed">36298613</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M, Zhang T, Shi G, Cheng F, Zheng Y, Tung T, et al. Safety of an inactivated SARS-CoV-2 vaccine among healthcare workers in China. Expert Rev Vaccines. 2021;20(7):891–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8127168</ArticleId><ArticleId IdType="pubmed">33929930</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan S, Yang Y, Zhang M, Tung T. Willingness to pay for booster dose of COVID-19 vaccine among healthcare workers in Taizhou,China. Hum Vaccin Immunother. 2022;18(5):2063629.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9897656</ArticleId><ArticleId IdType="pubmed">35522922</ArticleId></ArticleIdList></Reference><Reference><Citation>Tung T, Lin X, Chen Y, Zhang M, Zhu J. Willingness to receive a booster dose of inactivated coronavirus disease 2019 vaccine in Taizhou, China. Expert Rev Vaccines. 2022;21(2):261–7.</Citation><ArticleIdList><ArticleId IdType="pubmed">34894991</ArticleId></ArticleIdList></Reference><Reference><Citation>Randolph H, Barreiro L. Herd immunity: understanding COVID-19. Immunity. 2020;52(5):737–41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7236739</ArticleId><ArticleId IdType="pubmed">32433946</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiysonge C, Ndwandwe D, Ryan J, Jaca A, Batouré O, Anya B, et al. Vaccine hesitancy in the era of COVID-19: could lessons from the past help in divining the future? Hum Vaccin Immunother. 2022;18(1):1–3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8920215</ArticleId><ArticleId IdType="pubmed">33684019</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu R, Shi G, Zheng S, Tung T, Zhang M. COVID-19 vaccine hesitancy between family decision-makers and non-decision-makers among college teachers. Ann Med. 2023;55(1):292–304.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9815219</ArticleId><ArticleId IdType="pubmed">36594480</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Y, Zhao Y, Zhang T, Wang Q, Liu J. Factors associated with the vaccination behavior among COVID-19 vaccine hesitant college students in Wuhan, China: a survey based on social psychological dimension. Front Public Health. 2022;10:865571.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9130858</ArticleId><ArticleId IdType="pubmed">35646770</ArticleId></ArticleIdList></Reference><Reference><Citation>Salazar T, Pollard D, Pina-Thomas D, Benton M. Parental vaccine hesitancy and concerns regarding the COVID-19 virus. J Pediatr Nurs. 2022;65:10–5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8970879</ArticleId><ArticleId IdType="pubmed">35367855</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong J, Xu X, Yang J, Zheng J, Dai S, Zhou J, et al. Knowledge about, attitude and acceptance towards, and predictors of intention to receive the COVID-19 vaccine among cancer patients in Eastern China: a cross-sectional survey. J Integr Med. 2022;20(1):34–44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8559872</ArticleId><ArticleId IdType="pubmed">34774463</ArticleId></ArticleIdList></Reference><Reference><Citation>Sallam M, Al-Sanafi M, Sallam M. A global map of COVID- 19 vaccine acceptance rates per country: an updated concise narrative review. J Multidiscip Healthc. 2022;15:21–45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8760993</ArticleId><ArticleId IdType="pubmed">35046661</ArticleId></ArticleIdList></Reference><Reference><Citation>Latkin C, Dayton L, Yi G, Colon B, Kong X. Mask usage, social distancing, racial, and gender correlates of COVID-19 vaccine intentions among adults in the US. PLoS ONE. 2021;16(2):e0246970.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7886161</ArticleId><ArticleId IdType="pubmed">33592035</ArticleId></ArticleIdList></Reference><Reference><Citation>Rane M, Kochhar S, Poehlein E, You W, Robertson M, Zimba R, et al. Determinants and trends of COVID-19 vaccine hesitancy and vaccine uptake in a national cohort of US adults: a longitudinal study. Am J Epidemiol. 2022;191(4):570–83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8755394</ArticleId><ArticleId IdType="pubmed">34999751</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallè F, Sabella E, Roma P, Da Molin G, Diella G, Montagna M, et al. Acceptance of COVID-19 vaccination in the elderly: a cross-sectional study in Southern Italy. Vaccines (Basel). 2021;9(11):1222.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8618111</ArticleId><ArticleId IdType="pubmed">34835152</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Hanawi M, Alshareef N, El-Sokkary R. Willingness to receive COVID-19 vaccination among older adults in Saudi Arabia: a community-based survey. Vaccines (Basel). 2021;9(11):1257.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8621281</ArticleId><ArticleId IdType="pubmed">34835188</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker A, Atshan S, Walsh M, Gidengil C, Vardavas R. Association of COVID-19 vaccination with influenza vaccine history and changes in influenza vaccination. JAMA Netw Open. 2022;5(11):e2241888.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9664264</ArticleId><ArticleId IdType="pubmed">36374504</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin X, Li A, Zhang M, Lv L, Chen Y, Chen H, et al. Willingness of older adults with chronic diseases to receive a booster dose of inactivated coronavirus disease 2019 vaccine: a cross-sectional study in Taizhou, China. Vaccines (Basel). 2022;10(10):1665.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9611491</ArticleId><ArticleId IdType="pubmed">36298530</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohseni Afshar Z, Babazadeh A, Janbakhsh A, Mansouri F, Sio T, Sullman M, et al. Coronavirus disease 2019 (Covid-19) vaccination recommendations in special populations and patients with existing comorbidities. Rev Med Virol. 2022;32(3):e2309.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8646697</ArticleId><ArticleId IdType="pubmed">34677889</ArticleId></ArticleIdList></Reference><Reference><Citation>Manley H, Stewart C, Ladik V, Hosford J, Lacson E, Johnson D, et al. COVID-19 among US dialysis patients: risk factors and outcomes from a national dialysis provider. Am J Kidney Dis. 2021;77(5):748–e561.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7816961</ArticleId><ArticleId IdType="pubmed">33465417</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall V, Ferreira V, Ku T, Ierullo M, Majchrzak-Kita B, Chaparro C, et al. Randomized trial of a third dose of mRNA-1273 vaccine in transplant recipients. N Engl J Med. 2021;385(13):1244–6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8385563</ArticleId><ArticleId IdType="pubmed">34379917</ArticleId></ArticleIdList></Reference><Reference><Citation>Anand S, Montez-Rath M, Han J, Garcia P, Cadden L, Hunsader P, et al. Antibody response to COVID-19 vaccination in patients receiving dialysis. J Am Soc Nephrol. 2021;32(10):2435–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8722791</ArticleId><ArticleId IdType="pubmed">34117129</ArticleId></ArticleIdList></Reference><Reference><Citation>Grupper A, Sharon N, Finn T, Cohen R, Israel M, Agbaria A, et al. Humoral response to the Pfizer BNT162b2 vaccine in patients undergoing maintenance hemodialysis. Clin J Am Soc Nephrol. 2021;16(7):1037–42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8425628</ArticleId><ArticleId IdType="pubmed">33824157</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>